The principles of weight of evidence validation of test methods and testing strategies -: The report and recommendations of ECVAM Workshop 58a

被引:45
作者
Balls, Michael [1 ]
Amcoff, Patric
Bremer, Susanne
Casati, Silvia
Coecke, Sandra
Clothier, Richard
Combes, Robert
Corvi, Raffaella
Curren, Rodger
Eskes, Chantra
Fentem, Julia
Gribaldo, Laura
Halder, Marlies
Hartung, Thomas
Hoffmann, Sebastian
Schechtman, Leonard
Scott, Laurie
Spielmann, Horst
Stokes, William
Tice, Raymond
Wagner, Drew
Zuang, Valerie
机构
[1] European Commiss Joint Res Ctr, Inst Hlth & Consumer Protect, ECVAM, I-21020 Ispra, VA, Italy
[2] FRAME, Nottingham, England
[3] OECD, Environm Directorate, Paris, France
[4] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England
[5] Inst In Vitro Sci, Gaithersburg, MD USA
[6] Unilever, SEAC, Sharnbrook, Beds, England
[7] Natl Ctr Toxicol Res, Food & Drug Adm, Rockville, MD USA
[8] Fed Inst Risk Assessment, ZEBET, Berlin, Germany
[9] Natl Inst Environm Hlth Sci, Natl Toxicol Program, Interagcy Ctr Evaluat Alternat Toxicol Methods, Res Triangle Pk, NC USA
来源
ATLA-ALTERNATIVES TO LABORATORY ANIMALS | 2006年 / 34卷 / 06期
关键词
D O I
10.1177/026119290603400604
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:603 / 620
页数:18
相关论文
共 57 条
[1]  
[Anonymous], OECD PRINC VAL REG P
[2]  
BALLS M, 1990, ATLA-ALTERN LAB ANIM, V18, P313
[3]  
Balls M, 1995, ATLA-ALTERN LAB ANIM, V23, P884
[4]   The need for a formal invalidation process for animal and non-animal tests [J].
Balls, M ;
Combes, R .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2005, 33 (03) :299-308
[5]  
BALLS M, 1995, ATLA-ALTERN LAB ANIM, V23, P129
[6]  
BALLS M, 2006, ALTEX-ALTERN TIEREXP, V22, P288
[7]   Towards complete and,accurate reporting of studies of diagnostic accuracy: the STARD initiative [J].
Bossuyt, PM ;
Reitsma, JB ;
Bruns, DE ;
Gatsonis, CA ;
Glasziou, PP ;
Irwig, LM ;
Lijmer, JG ;
Moher, D ;
Rennie, D ;
de Vet, HCE .
BRITISH MEDICAL JOURNAL, 2003, 326 (7379) :41-44
[8]   Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use [J].
Corvi, R ;
Ahr, HJ ;
Albertini, S ;
Blakey, DH ;
Clerici, L ;
Coecke, S ;
Douglas, GR ;
Gribaldo, L ;
Groten, JP ;
Haase, B ;
Hamernik, K ;
Hartung, T ;
Inoue, T ;
Indans, I ;
Maurici, D ;
Orphanides, G ;
Rembges, D ;
Sansone, SA ;
Snape, JR ;
Toda, E ;
Tong, WD ;
van Delft, JH ;
Weis, B ;
Schechtman, LM .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2006, 114 (03) :420-429
[9]   ICCVAM evaluation of the murine local lymph node assay - II. Conclusions and recommendations of an independent scientific peer review panel [J].
Dean, JH ;
Twerdok, LE ;
Tice, RR ;
Sailstad, DM ;
Hattan, DG ;
Stokes, WS .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2001, 34 (03) :258-273
[10]  
*ECVAM, 2000, ATLA-ALTERN LAB ANIM, V28, P365